


New startup Aglaia Therapeutics raises €4M in seed funding to overcome resistance in oncology targeted therapies

Advent France Biotechnology creates Thabor Therapeutics and finances its seed

Geoffroy de Ribains promoted to partner at Advent France Biotechnology
